The McElrath laboratory applies multi-disciplinary and cross-platform approaches to their studies, which encompass the following research areas:
HIV Vaccine Trials Network (HVTN) Laboratory
Cape Town HVTN Immunology Laboratory
Seattle Vaccine Trials Unit (Seattle VTU)
Coronavirus, Malaria & Tuberculosis Vaccines
Infectious Diseases Clinical Research Consortium
Long Term Non-Progressor Cohort (LTNP)
Dr. Julie McElrath, holder of the Joel D. Meyers Endowed Chair, has witnessed the devastation of the HIV epidemic since the early 1980s as an infectious disease physician caring for patients and as a clinical researcher overseeing international collaborative cohort and vaccine studies that may inform and accelerate the development of vaccines for HIV and other significant global pathogens. She is the Principal Investigator of the HIV Vaccine Trials Network (HVTN) Laboratory Center and the Seattle Vaccine Trials Unit, and has led several projects within the Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) and NIH Consortia for HIV/AIDS Vaccine Development.